Intercure Cash Flow Conversion Efficiency

Latest as of December 2025: 0.006x

Intercure cash flow conversion efficiency. Based on the latest financial reports, Intercure (INCR) has a cash flow conversion efficiency ratio of 0.006x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA2.32 Million ≈ $6.22K USD) by net assets (ILA396.36 Million ≈ $1.06 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Intercure (2010–2025)

Cash flow conversion efficiency of Intercure from 2010 to 2025. This chart illustrates how Intercure's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Intercure stock price for real-time trading data and today's change.

Intercure Cash Flow Conversion Ratio Explained

Intercure cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Intercure Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Intercure ranked by their cash flow conversion efficiency. Also see INCR stock market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Humm Group Ltd AU:HUM	0.125x
Insecticides (India) Limited NSE:INSECTICID	-0.100x
Southland Holdings Inc. NASDAQ:SLND	0.067x
Lotte Chemical Titan Holding BHD KLSE:5284	-0.040x
QINGCI GAMES INC. -00001 F:Z56	N/A
The Ruby Mills Limited NSE:RUBYMILLS	-0.049x
PTT Synergy Group Bhd KLSE:7010	-0.233x
Hostelworld Group PLC IR:HSW	0.075x

Annual Cash Flow Conversion Efficiency for Intercure (2010–2025)

The table below shows the annual cash flow conversion efficiency of Intercure from 2010 to 2025. Review Intercure (INCR) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	ILA396.36 Million ≈ $1.06 Million	ILA16.84 Million ≈ $45.15K	0.042x	+125.25%
2024-12-31	ILA397.67 Million ≈ $1.07 Million	ILA-66.93 Million ≈ $-179.43K	-0.168x	-43.43%
2023-12-31	ILA457.06 Million ≈ $1.23 Million	ILA-53.63 Million ≈ $-143.78K	-0.117x	-219.35%
2022-12-31	ILA521.48 Million ≈ $1.40 Million	ILA51.27 Million ≈ $137.45K	0.098x	+80.43%
2021-12-31	ILA459.19 Million ≈ $1.23 Million	ILA25.02 Million ≈ $67.08K	0.054x	+103.97%
2020-12-31	ILA292.11 Million ≈ $783.13K	ILA7.80 Million ≈ $20.92K	0.027x	+270.54%
2019-12-31	ILA256.20 Million ≈ $686.87K	ILA-4.01 Million ≈ $-10.76K	-0.016x	+79.27%
2018-12-31	ILA19.66 Million ≈ $52.71K	ILA-1.49 Million ≈ $-3.98K	-0.076x	-69.69%
2017-12-31	ILA20.68 Million ≈ $55.44K	ILA-921.03K ≈ $-2.47K	-0.045x	+8.33%
2016-12-31	ILA24.07 Million ≈ $64.53K	ILA-1.17 Million ≈ $-3.14K	-0.049x	+65.72%
2015-12-31	ILA11.95 Million ≈ $32.05K	ILA-1.69 Million ≈ $-4.54K	-0.142x	+94.79%
2014-12-31	ILA697.01K ≈ $1.87K	ILA-1.90 Million ≈ $-5.08K	-2.721x	-220.50%
2013-12-31	ILA3.92 Million ≈ $10.50K	ILA-3.33 Million ≈ $-8.92K	-0.849x	-433.44%
2012-12-31	ILA9.84 Million ≈ $26.37K	ILA-1.57 Million ≈ $-4.20K	-0.159x	-1056.85%
2011-12-31	ILA-51.72 Million ≈ $-138.66K	ILA-860.16K ≈ $-2.31K	0.017x	-93.72%
2010-12-31	ILA-12.03 Million ≈ $-32.26K	ILA-3.19 Million ≈ $-8.54K	0.265x	--

About Intercure

TA:INCR Israel Drug Manufacturers - Specialty & Generic

Market Cap

$176.42 Million

ILA65.80 Billion ILA

Market Cap Rank

#16899 Global

#202 in Israel

Share Price

ILA1111.00

Change (1 day)

-5.04%

52-Week Range

ILA228.00 - ILA1794.00

All Time High

ILA6317.95